8-K - Aardvark Therapeutics, Inc. (0001774857) (Filer)
Published . Updated .
8-K - Aardvark Therapeutics filed an 8-K with the SEC on Oct 22 (a notice of a material company event).
Directly affected
- AARD Aardvark Therapeutics
Named in this report.
Indirectly affected
- SPY SPDR S&P 500
The broad U.S. stock market
- TLT iShares 20+ Year Treasury Bond
Long-term U.S. government bonds
- QQQ Invesco QQQ
Large technology stocks
- GLD SPDR Gold Shares
Gold can move with the broad market
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| AARD | -4.07% | -1.27% | base | after close | after close | after close | after close |
| SPY | -0.09% | +0.66% | base | after close | after close | after close | after close |
| TLT | -2.07% | -1.97% | base | after close | after close | after close | after close |
| QQQ | +0.75% | +1.80% | base | after close | after close | after close | after close |
| GLD | +3.51% | +2.33% | base | after close | after close | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Filed: 2026-10-22 AccNo: 0001193125-26-428943 Size: 199 KB Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits
Source: sec-edgar
How far Aardvark Therapeutics (AARD) has moved since 22 Oct 2026
| Company | When | Move | Status |
|---|---|---|---|
| Aardvark Therapeutics (AARD) | three days earlier | -1.27% | final price |
| Aardvark Therapeutics (AARD) | five days earlier | -4.07% | final price |
| GLD | three days earlier | +2.33% | final price |
| GLD | five days earlier | +3.51% | final price |
| QQQ | three days earlier | +1.80% | final price |
| QQQ | five days earlier | +0.75% | final price |
| SPY | three days earlier | +0.66% | final price |
| SPY | five days earlier | -0.09% | final price |
| TLT | three days earlier | -1.97% | final price |
| TLT | five days earlier | -2.07% | final price |
Who gains and who loses around Aardvark Therapeutics (AARD)
Companies carried with this story
- AARD Aardvark Therapeutics
Aardvark Therapeutics (AARD) is linked, with no stored direction, high confidence in the 22 Oct 2026 story “8-K - Aardvark Therapeutics, Inc. (0001774857) (Filer).” Reason on file: SEC 8-K filing -> direct issuer disclosure -> AARD
How “8-K - Aardvark Therapeutics, Inc. (0001774857) (Filer)” reaches Aardvark Therapeutics (AARD)
On 22 Oct 2026, “8-K - Aardvark Therapeutics, Inc. (0001774857) (Filer)” is the story that connects Aardvark Therapeutics (AARD) to this story.
Aardvark Therapeutics (AARD) is on the page because SEC 8-K filing -> direct issuer disclosure -> AARD
The price range for Aardvark Therapeutics (AARD), and the dates in the story
AARD traded between 3.67 and 5.84 across 16 sessions. The latest close on file is 4.45.
What the saved facts support for Aardvark Therapeutics (AARD)
14 out of 100
“8-K - Aardvark Therapeutics, Inc. (0001774857) (Filer)” scores 14 out of 100. The score uses 1 sources, and 1 linked companies.